142 related articles for article (PubMed ID: 10079292)
1. Role of the interferon-stimulated response element in HLA-B downregulation in human melanoma cell lines.
Griffioen M; Ouwerkerk IJ; Harten V; Gobin SJ; van den Elsen PJ; Schrier PI
Immunogenetics; 1999 Apr; 49(4):287-94. PubMed ID: 10079292
[TBL] [Abstract][Full Text] [Related]
2. HLA-B locus-specific downregulation in human melanoma requires enhancer A as well as a sequence element located downstream of the transcription initiation site.
Griffioen M; Ouwerkerk IJ; Harten V; Schrier PI
Immunogenetics; 2000 Nov; 52(1-2):121-8. PubMed ID: 11132148
[TBL] [Abstract][Full Text] [Related]
3. The human leukocyte antigen A2 interferon-stimulated response element consensus sequence binds a nuclear factor required for constitutive expression.
Waring JF; Radford JE; Burns LJ; Ginder GD
J Biol Chem; 1995 May; 270(20):12276-85. PubMed ID: 7744880
[TBL] [Abstract][Full Text] [Related]
4. Identification of CCAAT displacement protein (CDP/cut) as a locus-specific repressor of major histocompatibility complex gene expression in human tumor cells.
Snyder SR; Wang J; Waring JF; Ginder GD
J Biol Chem; 2001 Feb; 276(7):5323-30. PubMed ID: 11084046
[TBL] [Abstract][Full Text] [Related]
5. C-myc represses transiently transfected HLA class I promoter sequences not locus-specifically.
Griffioen M; Peltenburg LT; van Oorschot DA; Schrier PI
Immunobiology; 1995 Jul; 193(2-4):238-47. PubMed ID: 8530149
[TBL] [Abstract][Full Text] [Related]
6. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
7. HLA-B down-regulation in human melanoma is mediated by sequences located downstream of the transcription-initiation site.
Griffioen M; Ouwerkerk IJ; Harten V; Schrier PI
Int J Cancer; 1999 Feb; 80(4):573-80. PubMed ID: 9935159
[TBL] [Abstract][Full Text] [Related]
8. Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter.
Deffrennes V; Vedrenne J; Stolzenberg MC; Piskurich J; Barbieri G; Ting JP; Charron D; Alcaïde-Loridan C
J Immunol; 2001 Jul; 167(1):98-106. PubMed ID: 11418637
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.
Peltenburg LT; Dee R; Schrier PI
Nucleic Acids Res; 1993 Mar; 21(5):1179-85. PubMed ID: 8464702
[TBL] [Abstract][Full Text] [Related]
10. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
11. HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons.
Johnson DR; Pober JS
Mol Cell Biol; 1994 Feb; 14(2):1322-32. PubMed ID: 8289810
[TBL] [Abstract][Full Text] [Related]
12. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
[TBL] [Abstract][Full Text] [Related]
14. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element.
Gobin SJ; van Zutphen M; Woltman AM; van den Elsen PJ
J Immunol; 1999 Aug; 163(3):1428-34. PubMed ID: 10415043
[TBL] [Abstract][Full Text] [Related]
15. Repression of the minimal HLA-B promoter by c-myc and p53 occurs through independent mechanisms.
Griffioen M; Steegenga WT; Ouwerkerk IJ; Peltenburg LT; Jochemsen AG; Schrier PI
Mol Immunol; 1998 Sep; 35(13):829-35. PubMed ID: 9839551
[TBL] [Abstract][Full Text] [Related]
16. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
[TBL] [Abstract][Full Text] [Related]
17. Regulation of HLA-DR and costimulatory B7 molecules in human thyroid carcinoma cells: differential binding of transcription factors to the HLA-DRalpha promoter.
Lahat N; Rahat MA; Sadeh O; Kinarty A; Kraiem Z
Thyroid; 1998 May; 8(5):361-9. PubMed ID: 9623725
[TBL] [Abstract][Full Text] [Related]
18. A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta.
Lefebvre S; Berrih-Aknin S; Adrian F; Moreau P; Poea S; Gourand L; Dausset J; Carosella ED; Paul P
J Biol Chem; 2001 Mar; 276(9):6133-9. PubMed ID: 11087747
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.
Peltenburg LT; Schrier PI
Immunogenetics; 1994; 40(1):54-61. PubMed ID: 8206526
[TBL] [Abstract][Full Text] [Related]
20. High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.
Hurks HM; Metzelaar-Blok JA; Mulder A; Claas FH; Jager MJ
Int J Cancer; 2000 Mar; 85(5):697-702. PubMed ID: 10699951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
